Substack · BioEquity Watch
DD: BioCryst Pharmaceuticals
Rating: BULLISH | Target Price: $22.00 | Current Price: $9.20 | Implied Upside: +139%
Since publication BCRX −8.6% α −12.3 pp vs S&P 500 · USD
US · 1 entry · 1 publication
BCRX
Biocryst Pharmaceuticals Inc
- Entries
- 1
- Bullish
- 1
- Bearish
- 0
- First
- May 8, 2026
- Latest
- May 8, 2026
More bullish than bearish among those that state a stance.
Jan 25 – Oct 26 · per month
Full performance tracking Pro · free during launch
Alpha of every thesis on BCRX at 1, 3 and 6 months and since publication, and the full chart vs its benchmark.Free during launch: log in or sign up with your email to see it.
Sign up freeTimeline
Newest to oldest- May 2026 1 entry
Prices as of the Oct 27, 2026 close. Past performance does not guarantee future results. Price-only, excluding dividends, in local currency. Data may be delayed or inaccurate. Not investment advice. How it is calculated.